Spect: Routine Retinopathy Screening at the Point of Care

article image

Spect is using telemedicine to enable primary care to capture retinal images and thereby increase access to screening for patients at risk of diabetic retinopathy, and in the future, to help first-line clinicians detect signs of other diseases.

Diabetes is pervasive—it affects 10.5% of the population in the US—and so are its complications. Diabetic retinopathy is the leading cause of vision loss in working-age adults. Patients with diabetes should visit the ophthalmologist to be screened annually for the signs of diabetic retinopathy, which can lead to blindness if not diagnosed and treated early. Unfortunately, only 50% of the 27 million people with diabetes undergo annual eye screenings.


This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to MedTech Strategist:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to MedTech Strategist
Sign up for All-Access

Join our global community with a subscription to both MedTech Strategist and Market Pathways for one low price.



We're here to help! Please contact us at: